Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (ETR:MUV2)
Germany flag Germany · Delayed Price · Currency is EUR
510.80
-15.80 (-3.00%)
Apr 30, 2026, 5:35 PM CET

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Earnings Call Transcripts

Fiscal Year 2026

  • AGM 2026

    Record financial results in 2025 exceeded all strategic targets, with strong growth in ERGO, reinsurance, and specialty insurance. Leadership transitions and a new Ambition 2030 strategy focus on diversification, cost efficiency, and higher shareholder returns.

Fiscal Year 2025

  • Net earnings rose 8% to EUR 6.1 billion, with ROE at 18.3% and a 20% dividend increase. Diversified earnings, strong capital position, and disciplined underwriting drove results, while 2026 guidance targets further growth from less cyclical segments.

  • Record net earnings of EUR 6.1 billion were achieved, driven by strong diversified segment performance and disciplined capital management. Outlook for 2026 targets further growth, with increased dividends and share buybacks, despite competitive pressures in P&C reinsurance.

  • CMD 2025

    Ambition 2030 sets targets of >18% ROE, >8% EPS growth, and >80% payout, driven by diversification, efficiency, and technology. ERGO and reinsurance segments focus on AI, international growth, and alternative investments, while capital management ensures resilience and flexibility.

  • Q3 net result reached EUR 2 billion, with nine-month net income at EUR 5.2 billion, ahead of guidance. Strong technical results in P&C Reinsurance and GSI, robust capital position, and improved combined ratios support optimism for achieving or exceeding EUR 6 billion net income in 2025.

  • Net income reached EUR 3.2 billion in H1, with strong technical results in P&C reinsurance and global specialty insurance offsetting Q1 catastrophe losses. Despite a EUR 2 billion reduction in insurance revenue guidance due to currency effects, the group remains on track for record earnings in 2025.

  • Q1 net earnings reached EUR 1.1 billion, demonstrating resilience amid high losses and FX headwinds, with strong technical results in life and health reinsurance and solid performance from Ergo. Full-year guidance of EUR 6 billion net result is maintained, despite a more challenging growth outlook due to currency effects.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Powered by